» Articles » PMID: 7432169

Obesity and Lipoprotein Cholesterol in the Framingham Offspring Study

Overview
Journal Metabolism
Specialty Endocrinology
Date 1980 Oct 1
PMID 7432169
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

This study examines the relationship between obesity and low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, and very-low-density lipoprotein (VLDL) cholesterol in 4260 young adult men and women. The strongest association between obesity and LDL cholesterol was found in 20-29 yr-old males, the weakest in 40-49-yr-old males. Conversely, in women the relationship between LDL cholesterol and obesity was modest except in the oldest (40-49 yr) age group. An inverse relationship between obesity and HDL cholesterol was of similar shape and strength in all sex and age-specific groups. When the ratio of total cholesterol (TCHOL) to HDL cholesterol was compared in lean and grossly obese 20-29-yr-old males, substantial differences were found. Since other data show this index of the lipoprotein profile to be the single best indicator of CHD risk, it would appear that the atherogenic potential of obesity is greater than would be suggested by the relatively weak association between obesity and TCHOL or any single lipoprotein cholesterol. These data also suggest that the impact of obesity as a risk factor for CHD may have been underestimated. The paucity of lean males 40-49-yr-old prevents firm conclusions about the CHD risk in such a group. Indirect evidence indicates that lean 40-49-yr-old men would have a markedly more favorable lipoprotein profile and consequently a much lower risk of CHD.

Citing Articles

Characterising the genetic architecture of changes in adiposity during adulthood using electronic health records.

Venkatesh S, Ganjgahi H, Palmer D, Coley K, Linchangco Jr G, Hui Q Nat Commun. 2024; 15(1):5801.

PMID: 38987242 PMC: 11237142. DOI: 10.1038/s41467-024-49998-0.


Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024.

Bays H, Kirkpatrick C, Maki K, Toth P, Morgan R, Tondt J Obes Pillars. 2024; 10:100108.

PMID: 38706496 PMC: 11066689. DOI: 10.1016/j.obpill.2024.100108.


Risk of gastric cancer in relation with serum cholesterol profiles: A nationwide population-based cohort study.

Oh M, Han K, Kim B, Lim J, Kim B, Kim S Medicine (Baltimore). 2023; 102(48):e36260.

PMID: 38050195 PMC: 10695609. DOI: 10.1097/MD.0000000000036260.


Prevalence and risk factors of sarcopenia without obesity and sarcopenic obesity among Chinese community older people in suburban area of Shanghai: A cross-sectional study.

Lu L, He X, Song Y, Zhuang M, Wu X, Chen N Front Aging Neurosci. 2023; 14:1034542.

PMID: 36605360 PMC: 9807613. DOI: 10.3389/fnagi.2022.1034542.


COVID-19, body mass index and cholesterol: an ecological study using global data.

Sarmadi M, Ahmadi-Soleimani S, Fararouei M, Dianatinasab M BMC Public Health. 2021; 21(1):1712.

PMID: 34548066 PMC: 8453032. DOI: 10.1186/s12889-021-11715-7.